180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that it will effect a one-for-20 reverse stock split ("reverse split") of its common
Gainers
OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Gainers
COMSovereign Holding Corp. (NASDAQ: COMS) rose 20.9% to $0.1063 in pre-market trading after dipping 26% on Wednesday. COMSovereign recently announced receipt of Nasdaq listing determination.